Miniaturized FISH for screening of onco-hematological malignancies.

Fluorescence in situ hybridization (FISH) represents a major step in the analysis of chromosomal aberrations in cancer. It allows the precise detection of specific rearrangements, both for diagnostic and prognostic purposes. Here we present a miniaturized FISH method performed on fresh and fixed hematological samples. This procedure has been developed together with a microfluidic device that integrates cluster-assembled nanostructured TiO2 (ns-TiO2) as a nanomaterial promoting hematopoietic cell immobilization in conditions of shear stress. As a result of miniaturization, FISH can be performed with at least a 10-fold reduction in probe usage and minimal cell requirements, creating the possibility of using FISH in genetic screening applications. We developed the protocol on tumor cells and bone marrow (BM) from a normal donor using commercially sex-specific and onco-hematology probes. The procedure was then validated using either BM or peripheral blood (PB) from six patients with hematological diseases, each associated with different genetic lesions. Miniaturized FISH demonstrated comparable performance to standard FISH, indicating that it is suitable for genetic screenings, in research, and in clinical settings for the diagnosis of samples from onco-hematological malignancies.

[1]  A Gulino,et al.  Biotechnology and molecular diagnostics. , 1999, Forum.

[2]  Youl-Hee Cho,et al.  Molecular cytogenetic analysis of the monoblastic cell line U937. karyotype clarification by G-banding, whole chromosome painting, microdissection and reverse painting, and comparative genomic hybridization. , 2002, Cancer genetics and cytogenetics.

[3]  Vincent J Sieben,et al.  An integrated microfluidic chip for chromosome enumeration using fluorescence in situ hybridization. , 2008, Lab on a chip.

[4]  L. Kearney,et al.  The impact of the new FISH technologies on the cytogenetics of haematological malignancies , 1999, British journal of haematology.

[5]  Andre Levchenko,et al.  Microfluidics technology for systems biology research. , 2009, Methods in molecular biology.

[6]  K. Abromeit.  Music Received , 2023, Notes.

[7]  P. Milani,et al.  Biocompatibility of cluster-assembled nanostructured TiO2 with primary and cancer cells. , 2006, Biomaterials.

[8]  A. Seppo,et al.  Gain of 3q26: a genetic marker in low-grade squamous intraepithelial lesions (LSIL) of the uterine cervix. , 2009, Gynecologic oncology.

[9]  G Hermanson,et al.  High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. , 1990, Science.

[10]  Y. Zhang,et al.  Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization. , 2007, Experimental oncology.

[11]  Nicolas H Voelcker,et al.  Porous silicon biosensors on the advance. , 2009, Trends in biotechnology.

[12]  Judit M Nagy,et al.  Proteomics, nanotechnology and molecular diagnostics , 2008, Proteomics.

[13]  Paolo Milani,et al.  Cluster beam deposition: a tool for nanoscale science and technology , 2006 .

[14]  James C Baygents,et al.  Detachment of captured cancer cells under flow acceleration in a bio-functionalized microchannel. , 2009, Lab on a chip.

[15]  Andreas Manz,et al.  Microfluidics: Applications for analytical purposes in chemistry and biochemistry , 2008, Electrophoresis.

[16]  M. Tibiletti,et al.  Interphase FISH as a new tool in tumor pathology , 2007, Cytogenetic and Genome Research.

[17]  P. Pilarski,et al.  FISH and chips: chromosomal analysis on microfluidic platforms. , 2007, IET nanobiotechnology.

[18]  B. Johansson,et al.  The impact of translocations and gene fusions on cancer causation , 2007, Nature Reviews Cancer.

[19]  Daniel T Chiu,et al.  Disposable microfluidic devices: fabrication, function, and application. , 2005, BioTechniques.

[20]  P. Milani,et al.  Supersonic cluster beam deposition of nanostructured titania , 2003 .

[21]  E. Volpi,et al.  FISH glossary: an overview of the fluorescence in situ hybridization technique. , 2008, BioTechniques.

[22]  Y. Lotan,et al.  Prospective validation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder. , 2008, The Journal of urology.

[23]  Frederick L Kiechle,et al.  Point-of-care testing and molecular diagnostics: miniaturization required. , 2009, Clinics in laboratory medicine.

[24]  K. Jain,et al.  Applications of nanobiotechnology in clinical diagnostics. , 2007, Clinical chemistry.